found higher rates of COVID-19 hospitalization in psoriasis patients exposed to methotrexate than to TNF inhibitors, but similar rates of SARS-CoV-2 infection (34), and that methotrexate intake independently predicted COVID-19 related hospitalizations (40). The gene discussed is TNF; the disease is COVID-19.